BioSig Technologies, Inc. announced that it has installed a second evaluation system at the Cleveland Clinic. The additional installation will support the medical center's clinical evaluation of the PURE EP System and expand physician access to the Company's signal processing technology. Consistent with its stated national commercial strategy, the Company's customer-centered approach aims to maximize the clinical value and deployment of the PURE EP System which has gained interest in several electrophysiology labs in the Midwest.
The Company recently expanded its clinical footprint in Illinois with an additional evaluation agreement at a leading medical center in Springfield, the state capital.